about
Mast cells in meningiomas and brain inflammationPathophysiological Role of Neuroinflammation in Neurodegenerative Diseases and Psychiatric DisordersModulatory effects of α7 nAChRs on the immune system and its relevance for CNS disordersThe Impact of Neuroimmune Alterations in Autism Spectrum DisorderBrain "fog," inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolinPerinatal stress, brain inflammation and risk of autism-review and proposal.Evidence for cognitive impairment in mastocytosis: prevalence, features and correlations to depression.The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cellsNeuro-inflammation, blood-brain barrier, seizures and autism.Male gender bias in autism and pediatric autoimmunityMaternal immune activation by poly I:C induces expression of cytokines IL-1β and IL-13, chemokine MCP-1 and colony stimulating factor VEGF in fetal mouse brain.Beneficial Effects of Palmitoylethanolamide on Expressive Language, Cognition, and Behaviors in Autism: A Report of Two Cases.Fibromyalgia syndrome in need of effective treatments.Corticotropin-releasing hormone and extracellular mitochondria augment IgE-stimulated human mast-cell vascular endothelial growth factor release, which is inhibited by luteolinPlasma cytokine profiling in sibling pairs discordant for autism spectrum disorderFocal brain inflammation and autism.Subclinical inflammatory status in Rett syndrome.Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala.Mast cells, glia and neuroinflammation: partners in crime?Association Between Atopic Dermatitis and Autism Spectrum Disorders: A Systematic Review.Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism.Autologous bone marrow mononuclear cell therapy for autism: an open label proof of concept study.Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6.Opioid signaling in mast cells regulates injury responses associated with heterotopic ossificationA case series of a luteolin formulation (NeuroProtek®) in children with autism spectrum disorders.Suppression of Brain Mast Cells Degranulation Inhibits Microglial Activation and Central Nervous System Inflammation.An Inflammation-Centric View of Neurological Disease: Beyond the Neuron.
P2860
Q21146660-C1A39A31-7055-4F9F-B10F-14C58690725AQ26745690-CB61B52B-DF83-4E79-A79F-8BBADF34C61DQ26765419-ED84D4A9-AA96-4663-B208-527BC5E2F34DQ26781540-33CE5247-CD32-4106-8A72-2B5E5C10160AQ26802187-C0540535-4D22-43A6-BB47-F3D7B8C1765DQ34285045-007ED8CA-3672-44A1-B54A-676B4B6F7801Q34321423-0F7DE7C6-8D7F-4345-981A-5C4685136A85Q35305446-889DE779-A0A0-4B15-920B-97037B06BB5DQ35800334-761C0290-DB25-4240-B6A4-3EC2336C08EEQ35933457-279DB102-00E0-4047-842E-F3D68681F20DQ36146434-6A29F93E-AFEF-4984-84D2-F19BC6F8C860Q36150334-ADF8B3BD-E326-451F-B783-DF48F0D57443Q36186172-4A7DC93B-41FD-44E1-8253-CD9567191479Q36298946-BB2DC247-F24A-4DD9-8D85-DBEBD8ED284EQ36741348-8F84A8FD-4000-470B-876D-9EB5E8E79A3AQ36766675-3D4FBC4A-6C85-45D8-AB43-530CCCD6C613Q37553416-DA2FE768-B69B-4FCD-812A-BD3D11B4243BQ37661363-48579496-4138-412B-8A31-7DE6D44BF785Q38137173-D9B8B0E4-73EA-4BC7-9FB8-A4AF444BBA0AQ38562758-292FB942-16A3-40DD-A3BC-7FA4B145D5EEQ39324090-ED26B0A6-0C32-47E1-ACD1-669E0541C6FBQ39345467-FBABC715-44BB-4C28-B010-BB87F15292E4Q41270272-B36E222C-65A8-4E6D-9638-26F4A532F3CBQ41999303-58C27374-E517-4336-9E8C-290CEF487679Q48474072-C81B63C8-C07B-477E-BEC5-B54FEB5453BEQ48956990-7A384B9E-75B5-420A-8DB5-B9D2E40FE0B5Q52331711-53C432EA-A9CB-47F8-A5A8-02CD7BA31496
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Mast cell activation and autism.
@ast
Mast cell activation and autism.
@en
Mast cell activation and autism.
@nl
type
label
Mast cell activation and autism.
@ast
Mast cell activation and autism.
@en
Mast cell activation and autism.
@nl
prefLabel
Mast cell activation and autism.
@ast
Mast cell activation and autism.
@en
Mast cell activation and autism.
@nl
P2093
P1476
Mast cell activation and autism.
@en
P2093
Asimenia Angelidou
Bodi Zhang
Dimitrios Kalogeromitros
Elena Toniato
Konstantinos Francis
Konstantinos-Dionysios Alysandratos
Shahrzad Asadi
Theoharis C Theoharides
P356
10.1016/J.BBADIS.2010.12.017
P407
P577
2010-12-28T00:00:00Z